# US 2018/0022674 A1 · Process for preparation of ospemifene

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0022674 A1
- Document ID: US20180022674A1
- Status: Published application
- Kind: A1
- Application number: 15/541,536
- Filed: 2016-01-06
- Published: 2018-01-25
- Earliest claimed: 2015-01-09
- Assignees: Glenmark Pharmaceuticals S.A.
- Applicants: Glenmark Pharmaceuticals Limited
- Inventors: Veerabhadra SWAMY; Kumar Hari BHUSHAN; Shekha Bhaskar BHIRUD; Dilipkumar Jibhau PATIL; Eknath Kundlik KHEMNAR
- Web page: https://patentgrep.com/patent/US20180022674A1

## CPC

- C07C 37/86: by treatment giving rise to a chemical modification (chemisorption C07C37/82)
- B01J 23/44: Palladium
- C07C 37/00: Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C 37/84: by crystallisation
- C07C 41/16: by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
- C07C 41/18: by reactions not forming ether-oxygen bonds
- C07C 41/22: by introduction of halogens; by substitution of halogen atoms by other halogen atoms
- C07C 41/26: by introduction of hydroxy or O-metal groups
- C07B 2200/09: Geometrical isomers
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07C 41/30: by increasing the number of carbon atoms, e.g. by oligomerisation
- Y02P 20/52: using catalysts, e.g. selective catalysts
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention relates to a process for the preparation of ospemifene and pharmaceutically acceptable salts thereof which comprises the step of recycling the undesired E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol.

## Claims

### Claim 1

A process for the preparation of ospemifene, a compound of formula I,
and pharmaceutically acceptable salts thereof, the process comprising:
(a) providing an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol;
(b) separating the desired Z-isomer, a compound of formula IIa, or a salt thereof and the undesired E-isomer, a compound of formula IIb, or a salt thereof from the isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol;
(c) recycling the undesired E-isomer, the compound of formula IIb, or a salt thereof to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol;
(d) optionally, repeating steps (b) and (c); and
(e) converting the Z-isomer of 4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol, the compound of formula IIa, or a salt thereof obtained in step (b) to ospemifene.

### Claim 2 (depends on 1)

The process of claim 1, wherein the desired Z-isomer, the compound of formula IIa, or a salt thereof is separated from the undesired E-isomer, the compound of formula IIb, or a salt thereof by a process comprising:
(i) subjecting the isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol to treatment with a base in a solvent to generate a reaction mixture;
(ii) separating the desired Z-isomer, the compound of formula IIa, or a salt thereof and the undesired E-isomer, the compound of formula IIb, or a salt thereof from the reaction mixture obtained in step (i); and
(iii) optionally, treating the separated Z-isomer, the compound of formula IIa, or a salt thereof and the E-isomer, the compound of formula IIb, or a salt thereof with an acid.

### Claim 3 (depends on 2)

The process of claim 2, wherein the desired Z-isomer, the compound of formula IIa, or a salt thereof and the undesired E-isomer, the compound of formula IIb, or a salt thereof are separated from the reaction mixture obtained in step (i), by any of the following:
(x) by carrying out step (i) in a solvent in which one of the isomers, or salt thereof is soluble and the other isomer, or salt thereof is insoluble and precipitates out; or
(y) by carrying out step (i) in a solvent and by adding an anti-solvent to it wherein one of the isomers, or salt thereof is precipitated out; or
(z) by removing the solvent of step (i) and adding a second solvent to it in which one of the isomers, or salt thereof is soluble and the other isomer, or salt thereof is insoluble and precipitates out.

### Claim 4 (depends on 3)

The process of claim 3, wherein the solvent in step (x) is selected from ketones, haloalkanes, hydrocarbons, water, or mixtures thereof.

### Claim 5 (depends on 1)

The process of claim 1, wherein the undesired E-isomer, the compound of formula IIb, or a salt thereof is recycled to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol by a process comprising:
(i) providing a solution of the E-isomer, the compound of formula IIb, or a salt thereof, in a solvent;
(ii) stirring and/or heating the solution obtained in step (i) to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol; and
(iii) isolating the isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol.

### Claim 6 (depends on 5)

The process of claim 5, wherein the step (ii) is carried out at a temperature in the range of 10° C. to 150° C.

### Claim 7 (depends on 5)

The process of claim 5, wherein the step (ii) is carried out until the content of the Z-isomer, the compound of formula IIa, is not less than 48% in the isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol.

### Claim 8 (depends on 1)

The process of claim 1, wherein the Z-isomer of 4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol, the compound of formula IIa, or a salt thereof is converted to ospemifene by a process comprising:
(i) reacting the Z-isomer, the compound of formula IIa, or a salt thereof with a compound of formula III,
wherein X is selected from the group consisting of Cl, Br, and I, to form a compound of formula IV;
(ii) converting the compound of formula IV to a compound of formula V;
and
(iii) deprotecting the compound of formula V to ospemifene.

### Claim 9 (depends on 8)

The process of claim 8, wherein the compound of formula IV is converted to the compound of formula V using oxalyl chloride and dimethyl formamide.

### Claim 10 (depends on 8)

The process of claim 8, wherein the compound of formula V is deprotected by hydrogenation using a palladium catalyst in the presence of an acid to give ospemifene.

### Claim 11 (depends on 1)

The process of claim 1, wherein the level of E-isomer of ospemifene is less than 0.10% w/w with respect to ospemifene, as determined by high performance liquid chromatography (HPLC).

### Claim 12 (depends on 8)

The process of claim 8, further comprising the steps of:
(a) providing a solution of ospemifene in a solvent selected from alcohols, nitriles, water, or mixture thereof;
(b) precipitating out ospemifene from the solution obtained in step (a); and
(c) isolating the solid formed in step (b) to give ospemifene, having a D50 particle size in the range of about 15 microns to about 75 microns and D90 particle size in the range of 50 microns to about 150 microns.

### Claim 13 (depends on 12)

The process of claim 12, wherein the step (a) is carried out at a temperature in the range of 40° C. to 120° C.

### Claim 14 (depends on 12)

The process of claim 12, wherein the step (b) is carried out at a temperature in the range of −5° C. to 30° C.

### Claim 15 (depends on 12)

The process of claim 12, wherein the step (b) is carried out without stirring the solution of ospemifene.
